首页> 外国专利> Molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis

Molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis

机译:染色体易位t(11; 18)(q21; q21)的分子特征及其与致癌作用的关系

摘要

Methods for determining whether a tissue sample or an analogue and/or derivative thereof comprises a cell with a chromosome (11:18) translocation associated with malignancies such as mucosa-associated lymphoid tissue (MALT) lymphomas. The invention further provides insight into a novel mechanism of transformation of primary cells. The mechanism involves expression of a fusion proteinaceous molecule comprising at least apoptosis inhibitor 2 (API2) or a functional part, derivative and/or analogue thereof fused to at least one other proteinaceous molecule. The invention also provides a novel nucleic acid sequence and proteinaceous molecule expressed from the sequence termed “MALT-lymphoma associated Translocation (MLT) protein.”
机译:用于确定组织样品或其类似物和/或其衍生物是否包含具有与诸如与粘膜相关的淋巴组织(MALT)淋巴瘤的恶性肿瘤相关的染色体(11:18)易位的细胞的方法。本发明进一步提供了对原代细胞转化的新机制的见解。该机制涉及表达融合蛋白分子,所述融合蛋白分子至少包含凋亡抑制剂2(API2)或其与至少一个其他蛋白分子融合的功能部分,衍生物和/或类似物。本发明还提供了由称为“ MALT-淋巴瘤相关易位(MLT)蛋白”的序列表达的新型核酸序列和蛋白质分子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号